FDA FINAL Guidance Benefit-Risk in Medical Devices

The US FDA issued a FINAL guidance entitled: “Factors to Consider Regarding Benefit-Risk in Medical Device Product Availability, Compliance, and Enforcement Decisions”. This defines FDA’s approach to evaluate the Risk-Benefit relationship when evaluating information about medical devices The guidance includes examples on how it applies this product availabilty (e.g., recalls and shortage) and also to compliance and enforcement decisions. It also includes a short Appendix on the relationship to ISO 14971 use of similar terms. The remaining appendices appear quite useful as checklists for things to consider and address in internal pre and post market risk evaluations and as a summary of the guidance.

Schedule Discussion with John F. Murray, Jr.

John is currently providing telephone and face-to-face meetings to discuss:  Cybersecurity, Part 11, 483 Response, design controls expectations for software documentation, and other topics.

Leave a message and we will contact you to schedule:

Corporate Office

Partners located in the US (CA, FL, MA, MN, TN) and Italy.